BC Innovations | Apr 18, 2018
Distillery Therapeutics


INDICATION: Breast cancer Patient sample, cell culture and mouse studies suggest inhibiting CDC25A, CDC25B and CDC25C could help treat breast cancer. In breast cancer patients, high tumor levels of CDC25A, CDC25B and CDC25C correlated with...
BC Week In Review | Dec 15, 1997
Clinical News

Mitotix regulatory update

Five U.S. Patents related to cell cycle regulation issued either to the company or to entities from which the company has exclusive licenses. No. 5,672,508, issued to Mitotix, claims nucleic acids that encode peptide fusions...
BC Week In Review | Aug 28, 1995
Clinical News

Mitotix regulatory update

Mitotix received U.S. Patent Nos. 5,441,880 and 4,443,962. The '880 patent, to which Mitotix has an exclusive worldwide license, issued to the Cold Spring Harbor Laboratory and covers human and recombinant versions of the proteins...
Items per page:
1 - 3 of 3